NSE - SMEListed
Zenith Drugs Limited

Zenith Drugs Limited

Company website
Zenith Drugs Limited targets ₹51,48,800 crore, split as fresh issue ₹51,48,800 crore and OFS ₹0 crore.
The offer represents 1600 shares. Apply from 19-02-2024 to 22-02-2024. Allotment on 23-02-2024, listing expected on 27-02-2024. Remember: subscription demand will influence listing-day price movements.
Start Date19-02-2024
End Date22-02-2024
Listing Date27-02-2024
Allotment Date23-02-2024
Current Price₹110
GMP₹35 (44.30%)
Lot Size1600 Shares
Subscription179.07 Times
Face Value₹10 Per Equity Share
Listing atNSE
Issue Price₹75 - ₹79
Pre Issue₹1,20,00,000
Post Issue₹1,71,48,800
Issue Size₹51,48,800
(aggregating up to 40.68 Cr)
Fresh Issue₹51,48,800
(aggregating up to 40.68 Cr)
Offer For Sale-
The Grey Market Premium (GMP) for Zenith Drugs Limited is currently around ₹35 (44.30%). This indicates an estimated listing price of approximately ₹110 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.

Gmp Details

Last UpdatedIPO PriceGMPEstimated Listing Price
20 Nov 2025, 07:04
₹79
₹35
₹114 (44.30%)
12 Mar 2025, 06:51
₹79
₹35
₹114 (44.30%)

Financials overview In Lakhs

Here is a quick look at the recent financial performance of Zenith Drugs Limited . The numbers below ( In Lakhs ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.

Key Performance

KPI202320222021
EPS
4.29
2.62
2.52
ROE
35.13
29.83
40.73
ROCE
37.29
30.08
36.52
RONW
29.88
25.96
33.84
PRE IPO(PE)
18.4
0
0
POST IPO(PE)
5.5
0
0

Subscription Demand (in ₹ Crore)

CategoryOfferedDemandTimes
QIBs
₹6.79
724.41
106.69
RETAIL
₹11.88
1646.4
138.59
Total
₹18.67
2370.81
126.99
The IPO reservation for Zenith Drugs Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.

IPO Reservation

CategoryShares OffersNo. of Shares
Retail
38.96%
15,04,000
NII(HNI)
16.70%
6,44,800
QIB
22.26%
8,59,200
Market Maker
22.09%
8,52,800
TOTAL
100.00%
38,60,800

Lot(s) Distribution

CategoryLot(s)QtyAmountReserved
Retail (Min)
1
1,600
₹1,26,400
0
HNI
2
3,200
₹2,52,800
0
Below you can find the official contact details of Zenith Drugs Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.

Company Details

Phone: +91 8435501867
Address: K. No. 72 / 5, Village Muradpura NA Depalpur, Indore-453001

IPO Registrar

Name: Bigshare Services Private Limited
Phone: +91-22-6263 8200
Zenith Drugs Limited IPO Details — GMP: ₹35 (44.30%) | Grey Market IPO